RESEARCH ALERT - MedPartners rated a buy.

-- UBS Securities analyst Erik Wiberg said in a research note that he initiated coverage of MedPartners with a with a buy recommendation.

-- 1996 earnings estimate is $0.87, 1997 is $1.12 and 1998 is $1.40.

-- Shares were trading off 3/8 at 21-7/8 in midmorning exchange trade.

